Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol in acute myocardial infarction with hyperuricemia
ChiCTR1900024152Phase 4Not yet recruiting
- Sponsor
- Xiamen Cardiovascular Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in hyperuricemia and myocardial infarction (MI) (2 arms), sponsored by Xiamen Cardiovascular Hospital. Primary endpoints: Cardiovascular death, Nonfatal myocardial infarction and 2 more. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
allopurinol
03
Conditions
hyperuricemiamyocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1900024152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024152.